Stanley J. Goldsmith

NANETS Treatment Guidelines

Matthew H. Kulke, Lowell Anthony, David Bushnell et al. · Pancreas · 2010 · 569 citations · Full text

Surgical Oncology, Oncology, Pancreatic Cancer +15

The NANETS Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors

J. Philip Boudreaux, David S. Klimstra, Manal M. Hassan et al. · Pancreas · 2010 · 525 citations

Surgical Oncology, Gastroenterology, Pathology +16

Phase I Trial of ¹⁷⁷Lutetium-Labeled J591, a Monoclonal Antibody to Prostate-Specific Membrane Antigen, in Patients With Androgen-Independent Prostate Cancer

Neil H. Bander, Matthew I. Milowsky, David M. Nanus et al. · Journal of Clinical Oncology · 2005 · 504 citations

Phase II Study of Lutetium-177–Labeled Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody J591 for Metastatic Castration-Resistant Prostate Cancer

Scott T. Tagawa, Matthew I. Milowsky, Michael J. Morris et al. · Clinical Cancer Research · 2013 · 414 citations · Full text

PET predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin's disease.

Lale Kostakoğlu, Morton Coleman, John P. Leonard et al. · PubMed · 2002 · 367 citations